Can targeted medication reduction improve health in older adults?
Researchers found that a targeted approach to reducing certain medications in older adults, known as focused deprescribing, may help manage the issue of polypharmacy, where individuals take multiple medications simultaneously. This strategy aims to withdraw or lower doses of specific drug classes, particularly psychotropic medications like benzodiazepines, which are often overprescribed among seniors. The findings suggest that focused deprescribing could be a more practical alternative to comprehensive medication reviews, which can be resource-intensive.
This matters for your health because many older adults are at risk of experiencing adverse effects from taking too many medications. By focusing on reducing specific classes of drugs, like benzodiazepines, people may potentially reduce their risk of side effects and improve their overall well-being. The review indicated that reducing the use of certain psychotropic medications could lead to better health outcomes, although the benefits vary depending on the drug class involved.
The evidence comes from an umbrella review of 27 systematic reviews, which evaluated the effectiveness and safety of focused deprescribing interventions. While the approach seems feasible and generally safe, the quality of the studies was often rated as critically low, and the certainty of the evidence was generally low or very low. This means that while the strategy shows promise, more robust research is needed to determine its true effectiveness and benefits for clinical outcomes like mortality, falls, and cognitive health.
If you’re considering medication changes, it’s essential to consult with a healthcare professional who can provide personalized advice and ensure that any deprescribing is done safely and effectively.